Preliminary experience offering oocyte donation to human immunodeficiency virus-1 serodiscordant couples

被引:3
作者
Joseph E. Peña
Melvin H. Thornton
Mark V. Sauer
机构
[1] Department of Obstetrics, C.-P. Med. Ctr. Columbia Univ., College of Physicians and Surgeons, New York, NY 10032
关键词
HIV; In vitro fertilization; Intracytoplasmic sperm injection; Oocyte donation; Serodiscordant;
D O I
10.1007/s00404-002-0458-5
中图分类号
学科分类号
摘要
Case report: Our preliminary experience on the use of donor oocytes in human immunodeficiency virus-1 (HIV-1) serodiscordant couples who have previously failed conventional in vitro fertilization (IVF) therapy is presented. Five HIV-1 serodiscordant couples in which the male is infected and the female is seronegative underwent IVF with intracytoplasmic sperm injection (ICSI) utilizing donor oocytes with day 3 embryo transfer and cryopreservation. Six oocyte donation cycles in the five couples yielded 16.8±9.5 (mean±SD) (range 11-34) oocytes; 3.8±0.4 (range 3-4) transferred embryos; and 1.8±2.2 (range 0-5) cryopreserved embryos per attempt. The fertilization rate from ICSI was 0.60±0.16 (range 0.40-0.88). Three of five couples conceived; two from one attempt (one singleton pregnancy and one twin pregnancy); and another after a failed fresh cycle using cryopreserved embryos. All female recipients tested remained seronegative 3 and 6 months post-embryo transfer. All babies (n=4) were seronegative at birth and 3 months postpartum. Conclusion: Oocyte donation may be considered as an alternative for childbearing in HIV serodiscordant couples in whom conventional IVF has failed due to factors inherent to the female partner.
引用
收藏
页码:202 / 205
页数:3
相关论文
共 16 条
[1]  
Human immunodeficiency virus: Ethical guidelines for obstetricians and gynecologists, Obstet Gynecol, 97, SUPPL., pp. 1-6, (2001)
[2]  
Human immunodeficiency virus and infertility treatment, Fertil Steril, 77, pp. 218-222, (2002)
[3]  
Connor E.M., Sperling R.S., Gelber R., Kiselev P., Scott G., O'Sullivan M.J., VanDyke R., Bey M., Shearer W., Jacobson R.L., Et al., Reduction of matemal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment, N Engl J Med, 331, pp. 1173-1180, (1994)
[4]  
Gray R.H., Wawer M.J., Brookmeyer R., Sewankambo N.K., Serwadda D., Wabwire-Mangen F., Lutalo T., Li X., VanCott T., Quinn T.C., Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda, Lancet, 357, pp. 1149-1153, (2001)
[5]  
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - A meta-analysis of 15 prospective cohort studies, N Engl J Med, 340, pp. 977-987, (1999)
[6]  
Lassalle B., Testart J., Renard J.P., Human embryo features that influence the success of cryopreservation with the use of 1,2 propanediol, Fertil Steril, 44, pp. 645-651, (1985)
[7]  
Loutradis D., Drakakis P., Kallianidis K., Patsoula E., Bletsa R., Michalas S., Birth of two infants who were seronegative for human immunodeficiency virus type 1 (HIV-1) after intracytoplasmic injection of sperm from HIV-1-seropositive men, Fertil Steril, 75, pp. 210-212, (2001)
[8]  
Marina S., Marina F., Alcolea R., Exposito R., Huguet J., Nadal J., Verges A., Human immunodeficiency virus type 1 - Serodiscordant couples can bear healthy children after undergoing intrauterine insemination, Fertil Steril, 70, pp. 35-39, (1998)
[9]  
Marina S., Marina F., Alcolea R., Nadal J., Exposito R., Huguet J., Pregnancy following intracytoplasmic sperm injection from an HIV-1-seropositive man, Hum Reprod, 13, pp. 3247-3249, (1998)
[10]  
Palermo G.D., Cohen J., Alikani M., Adler A., Rosenwaks Z., Development and implementation of intracytoplasmic sperm injection (ICSI), Reprod Fertil Dev, 7, pp. 211-217, (1995)